SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 76.26 |
| Enterprise Value ($M) | 159.23 |
| Book Value ($M) | 86.84 |
| Book Value / Share | 0.23 |
| Price / Book | 0.88 |
| NCAV ($M) | -69.16 |
| NCAV / Share | -0.18 |
| Price / NCAV | -1.10 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.08 |
| Return on Assets (ROA) | -0.07 |
| Return on Equity (ROE) | -0.16 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.49 |
| Current Ratio | 1.27 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 56.68 |
| Assets | 212.68 |
| Liabilities | 125.84 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| . UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| MLLCF – Molecular Partners AG | MLPH – Molecular Pharmacology (USA), Ltd. |
| MODVF – Melcor Developments Ltd. | MSLPQ – MusclePharm Corporation |
| MSTH – Mystic Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io